Scarica l'app Stockscreener
99.66
1.83%
-1.86
Dopo l'orario di chiusura:
99.66
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RVTY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$101.52
Aprire:
$102.34
Volume 24 ore:
927.41K
Relative Volume:
0.73
Capitalizzazione di mercato:
$11.12B
Reddito:
$2.90B
Utile/perdita netta:
$239.11M
Rapporto P/E:
47.24
EPS:
2.1097
Flusso di cassa netto:
$492.62M
1 W Prestazione:
+1.31%
1M Prestazione:
+0.36%
6M Prestazione:
-0.83%
1 anno Prestazione:
+4.14%
Intervallo 1D:
$98.42
$103.60
Intervallo di 1 settimana:
$98.42
$106.20
Portata 52W:
$81.22
$118.30
Revvity Inc Stock (RVTY) Company Profile
Nome
Revvity Inc
Settore
Industria
Telefono
781-663-6900
Indirizzo
77 4TH AVENUE, WALTHAM
Compare RVTY vs TMO, DHR, IDXX, A, WAT
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RVTY
Revvity Inc
|
99.66 | 11.12B | 2.90B | 239.11M | 492.62M | 2.1097 |
TMO
Thermo Fisher Scientific Inc
|
469.34 | 174.42B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
180.10 | 127.47B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
560.88 | 44.24B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
129.84 | 36.67B | 7.23B | 1.41B | 1.09B | 4.979 |
WAT
Waters Corp
|
355.53 | 34.91B | 3.77B | 449.25M | 240.68M | 7.8556 |
Revvity Inc Stock (RVTY) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-04-14 | Downgrade | Barclays | Overweight → Equal Weight |
| 2025-12-15 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-12-09 | Iniziato | Goldman | Neutral |
| 2025-10-16 | Iniziato | Guggenheim | Neutral |
| 2025-05-01 | Aggiornamento | UBS | Neutral → Buy |
| 2025-01-10 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2024-12-13 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-08 | Iniziato | Leerink Partners | Outperform |
| 2024-06-03 | Ripresa | Jefferies | Hold |
| 2024-01-16 | Downgrade | UBS | Buy → Neutral |
| 2024-01-04 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2023-12-19 | Iniziato | Wells Fargo | Equal Weight |
| 2023-12-13 | Iniziato | Wolfe Research | Peer Perform |
| 2023-09-28 | Iniziato | Bernstein | Outperform |
| 2023-07-19 | Iniziato | Raymond James | Outperform |
| 2023-05-23 | Ripresa | Goldman | Buy |
Mostra tutto
Revvity Inc Borsa (RVTY) Ultime notizie
RVTY Technical Analysis & Stock Price Forecast - Intellectia AI
Revvity Inc. Stock (US76155R1086): valuation focus after quiet trading - AD HOC NEWS
Revvity Inc. stock underperforms Friday when compared to competitors - MarketWatch
Revvity Opera Phenix Plus: high-content screening system in focus for US labs - AD HOC NEWS
Revvity Inc. Stock (US76155R1086): neutral day with the shares in focus - AD HOC NEWS
Revvity Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
What to expect from Revvity's next quarterly earnings report - MSN
Revvity Inc (RVTY) Shares Surge 3.8% -- What GF Score of 78 Tells Investors - GuruFocus
Revvity Inc. stock outperforms competitors on strong trading day - MarketWatch
Revvity stock (US76155R1086): investors eye diagnostics and life science tools story - AD HOC NEWS
Revvity Inc at Goldman Sachs Healthcare Conference Transcript - GuruFocus
Revvity (RVTY) Valuation Check After China Immunodiagnostics Exit Plan And Solid First Quarter Results - Yahoo Finance
Revvity stock edges higher above $99 as technical momentum holds after image of the month post - Traders Union
Revvity, Inc. (RVTY) Stock Analysis: A Compelling 15.53% Upside in the Healthcare Diagnostics Sector - DirectorsTalk Interviews
Dilution adjustment of Revvity, Inc. – XETR:PKN - TradingView
(RVTY) Volatility Zones as Tactical Triggers - Stock Traders Daily
Revvity, Inc. Trade Ideas — XETR:PKN - TradingView
Revvity, Inc. Cash Flow – XETR:PKN - TradingView
Revvity, Inc. Balance Sheet – XETR:PKN - TradingView
Stifel cuts Revvity stock price target on softer valuation - Investing.com
Revvity gains on diagnostics strength, faces China headwinds - MSN
Revvity Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
Why is Revvity (RVTY) up 2% since last earnings report? - MSN
Why Is Revvity (RVTY) Up 2% Since Last Earnings Report? - Yahoo Finance
Wolfe Research Initiates Revvity(RVTY.US) With Hold Rating - Moomoo
RVTY Assumed by Wolfe Research -- Rating Set to Peer Perform - GuruFocus
Revvity Inc (RVTY) Stock Down 3.9% -- Now Undervalued? GF Score: 74/100 - GuruFocus
Wolfe Research initiates Revvity stock coverage with Peerperform - Investing.com UK
Wolfe Research initiates Revvity stock coverage with Peerperform By Investing.com - Investing.com Nigeria
Revvity Inc. stock underperforms Monday when compared to competitors - MarketWatch
Why Is S&P 500 Attention on Revvity After Earnings Miss? - Kalkine Media
Research Tools & Consumables Stocks Q1 In Review: Revvity (NYSE:RVTY) Vs Peers - Yahoo Finance
Revvity, Inc. (RVTY) Stock Analysis: A Healthcare Innovator With 8.7% Potential Upside - DirectorsTalk Interviews
RVTY unveils Signals BioDesign for faster molecular cloning & R&D data - MSN
Revvity Inc. stock (US76155R1086): NYSE price holds near 100 USD as technical levels draw focus - AD HOC NEWS
Revvity Inc. stock (US76155R1086): insider activity and recent trading in focus - AD HOC NEWS
Revvity (RVTY) Q1 earnings and revenues top estimates - MSN
A Look at Revvity Inc (RVTY) After 4.6% Gain -- GF Value $120.39 vs Price $101.22 - GuruFocus
Revvity stock (US76155R1086): New share repurchase plan sets tone after recent earnings - AD HOC NEWS
Price-Driven Insight from (RVTY) for Rule-Based Strategy - Stock Traders Daily
RVTY Stock Price and Chart — NYSE:RVTY - TradingView
Revvity stock (US76155R1086): life-science player after recent earnings in focus - AD HOC NEWS
Revvity, Inc. (RVTY) Stock Analysis: A Blend of Healthcare Innovation and Notable Growth Potential - DirectorsTalk Interviews
Revvity stock: Analyst estimates & ratings - MSN
Revvity stock (US76155R1086): cancer test launch and steady demand keep diagnostics group in focus - AD HOC NEWS
Revvity declares $0.07 dividend - MSN
Revvity Inc Azioni (RVTY) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.38%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):